Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study: Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules

BACKGROUND: Our study was designed to improve the accuracy of determining whether pulmonary nodules are benign or malignant. METHODS: We evaluated the clinical and imaging features and serum markers: neuron specific enolase (NSE), carcino-embryonic antigen (CEA), cytokeratin fragment antigen 21–1...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xianfeng, Zhang, Qinghua, Jin, Xiayun, Cao, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445450/
https://www.ncbi.nlm.nih.gov/pubmed/28545454
http://dx.doi.org/10.1186/s12957-017-1171-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445450/
https://www.ncbi.nlm.nih.gov/pubmed/28545454
http://dx.doi.org/10.1186/s12957-017-1171-y

Ejemplares similares